The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding

Breast Cancer Research and Treatment

Volumn 138, Issue 2, 2013, Pages 395-406

  Rogozina, Olga P ^a   Nkhata, Katai J ^a   Nagle, Emily J ^a   Grande, Joseph P ^b   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Adiponectin; Breast cancer; Calorie restriction; Fat intake; IGF 1; Leptin; Mammary tumors; Prevention; Tumorigenesis

Indexed keywords

ADIPONECTIN; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST CARCINOGENESIS; CALORIC RESTRICTION; CANCER PREVENTION; CONTROLLED STUDY; FAT INTAKE; FEMALE; HISTOPATHOLOGY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; NUTRIENT CONTENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFEEDING;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CALORIC RESTRICTION; CELL TRANSFORMATION, NEOPLASTIC; DIET, HIGH-FAT; EATING; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84879414174     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2464-7     Document Type: Article

References (63)

1. Harvie M, Howell A (2006) Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention. Obes Rev 7:33-47
2. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW (1989) Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 49:4130-4134 (Pubitemid 19207248)
3. Klurfeld DM, Welch CB, Davis MJ, Kritchevsky D (1989) Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J Nutr 119:286-291 (Pubitemid 19080840)
4. Klurfeld DM, Lloyd LM, Welch CB et al (1991) Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction. Proc Soc Exp Biol Med 196:381-384
5. Fernandes G, Chandrasekar B, Troyer DA et al (1995) Dietary lipids and calorie restriction effect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl Acad Sci USA 92:6494-6498
6. Zhu Z, Haegele AD, Thompson HJ (1997) Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 18:1007-1012 (Pubitemid 28132347)
7. Dirx MJM, Zeegers MPA, Dagnelie PC et al (2003) Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106:766-770 (Pubitemid 36993402)
8. Bunk B, Zhu P, Klinga K et al (1992) Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br J Cancer 65:845-851
9. Beth M, Berger MR, Aksoy M, Schmahl D (1987) Comparison between the effects of dietary fat level and calorie intake on methlynitrosourea-induced mammary carcinogenesis in female SD rats. Int J Cancer 39:737-744 (Pubitemid 17087875)
10. Klurfeld DM, Welch CB, Lloyd LM, Kritchevsky D (1989) Inhibition of DMBA-induced mammary tumorigenesis by caloric restriction in rats fed high-fat diets. Int J Cancer 43:922-925 (Pubitemid 19138206)
11. Welsch CW, House JL, Herr BL et al (1990) Enhancement of mammary carcinogenesis by high levels of dietary fat: a phenomenon dependent on ad libitum feeding. J Natl Cancer Inst 82:1615-1620 (Pubitemid 20345297)
12. Boissonneault GA, Elson CE, Pariza MW (1986) Net energy effects of dietary fat on chemically induced mammary carcinogenesis in F344 rats. J Natl Cancer Inst 76:335-338 (Pubitemid 16130016)
13. Welsch CW (1992) Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 52:2040s-2048s
14. Cleary MP, Grande JP, Maihle NJ (2004) Effect of a high fat diet on body weight and mammary tumor latency in MMTV-TGF-α mice. Int J Obes 28:956-962 (Pubitemid 38998699)
15. Engelman RW, Day NK, Good RA (1994) Calorie intake during mammary development influences cancer risk: lasting inhibition of C3H/HeOu mammary tumorigenesis by peripubertal calorie restriction. Cancer Res 54:5724-5730
16. Chen R-F, Good RA, Engelman RW et al (1990) Suppression of mouse mammary tumor proviral DNA and protooncogene expression: association with nutritional regulation of mammary tumor development. Proc Natl Acad Sci USA 87:2385-2389
17. Carlson AJ, Hoelzel F (1946) Apparent prolongation of the life span of rats by intermittent fasting. J Nutr 31:363-375
18. Harris SR, Brix AE, Broderson JR, Bunce OR (1995) Chronic energy restriction versus energy cycling and mammary tumor promotion. Proc Soc Exp Biol Med 209:231-236
19. Tagliaferro AR, Ronan AM, Meeker LD et al (1996) Cyclic food restriction alters substrate utilization and abolishes protection from mammary carcinogenesis in female rats. J Nutr 126:1398-1405 (Pubitemid 26137700)
20. Cleary MP, Jacobson MK, Phillips FC et al (2002) Weight-cycling decreases incidence and increases latency of mammary tumor development to a greater extent than does chronic restriction in mouse mammary tumor virus-transforming growth factor-α female mice. Cancer Epidemiol Biomarkers Prev 11:836-843 (Pubitemid 35014886)
21. Cleary MP, Hu X, Grossmann ME et al (2007) Prevention of mammary tumorigenesis by intermittent caloric restriction, does caloric intake during refeeding modulate the response? Exp Biol Med. 232:70-80 (Pubitemid 46089942)
22. Rogozina OP, Bonorden MJL, Grande JP, Cleary MP (2009) Serum insulin like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted and intermittent calorie-restricted MMTV-TGF-α mice. Cancer Prev Res 2:712-719
23. Pape-Ansorge KA, Grande JP, Christensen TA et al (2002) Effect of moderate caloric restriction and/or weight-cycling on mammary tumor incidence and latency in MMTV-neu female mice. Nutr Cancer 44:161-168 (Pubitemid 36637946)
24. Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114:71-83 (Pubitemid 351998746)
25. Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189-206 (Pubitemid 47242622)
26. Barb D, Pazaitou-Panayiotou K, Mantzoros CS (2006) Adiponectin: a link between obesity and cancer. Expert Opin Investig Drugs 15:917-933 (Pubitemid 44177844)
27. Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin- a growth factor for normal and malignant breast cells and normal mammary gland development. J Natl Cancer Inst 94:1704-1711 (Pubitemid 35446839)
28. Laud K, Gourdou I, Pessemesse L et al (2002) Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188:219-226 (Pubitemid 34242679)
29. Dieudonne M-N, Machinal-Quelin F, Serazin-Leroy V et al (2002) Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293:622-628 (Pubitemid 34694255)
30. Ray A, Nkhata KJ, Cleary MP (2007) Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30:1499-1509
31. Garofalo C, Sisci D, Surmacz E (2004) Leptin interferes with the effects of the antiestrogen ICI 182.780 in MCF-7 breast cancer cell lines. Clin Cancer Res 10:6466-6475 (Pubitemid 39346542)
32. Dieudonne M-N, Bussiere M, Dos Santos E et al (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271-279
33. Grossmann ME, Nkhata KJ, Mizuno NK et al (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370-378 (Pubitemid 351161253)
34. Takahata C, Miyoshi Y, Irahara N et al (2007) Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett 250:229-236 (Pubitemid 46529445)
35. Körner A, Pazaitou-Panayiotou K, Kelesidis T et al (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041-1048 (Pubitemid 46465681)
36. Chen D-C, Chung Y-F, Yeh Y-T et al (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109-114
37. Mantzoros C, Petridou E, Dessypris N et al (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102-1107 (Pubitemid 38368397)
38. Grossmann ME, Ray A, Dogan S et al (2008) Balance of adiponectin and leptin in relationship to breast cancer cell growth. Cell Res 18:1154-1156
39. Rogozina OP, Bonorden MJL, Seppanen C et al (2011) Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res 4:568-581
40. Dogan S, Rogozina OP, Loshkin A et al (2010) Effects of chronic vs intermittent calorie restriction on mammary tumor incidence and serum adiponecin and leptin levels in MMTV-TGF-α mice at different ages. Oncol Lett 1:167-176
41. Shankaraiah K, Halberg F, Yunis E, Watson LM (1984) Alternate-day feeding alters the circadian system, reduces breast cancer incidence and prolongs life. In: Halberg F, Reale L, Tarquini B (eds) Proceedings of II international symposium on chronobiologic approach to social medicine. Instituto Itaniano di Medicina Sociale, Rome, pp 633-648
42. Shao R, Dao ML, Day NK, Good RA (1990) Dietary manipulation of mammary tumor development in adult C3H/Bi mice. Proc Soc Exp Biol Med 193:313-317 (Pubitemid 20124767)
43. Buison AM, Pellizzon MA, Brogan KE et al (2005) Weight cycling did not increase tumor incidence in high fat-fed rats treated with a low-dose 7,12-dimethylbenzyl(1)anthracene. Nutr Res. 25:1097-1108 (Pubitemid 41739819)
44. Bonorden MJL, Rogozina OP, Kluczny CM et al (2009) Intermittent caloric restriction delays tumor detection and increases survival in TRAMP mice. Nutr Cancer 61:265-275
45. Bonorden MJL, Rogozina OP, Kluczny CM et al (2009) Cross-sectional analyses of intermittent versus chronic caloric restriction in the TRAMP mouse. Prostate 69:317-326
46. Buschemeyer WC III, Klink JC, Mavropoulos JC et al (2010) Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice. Prostate 70:1037-1043
47. Descamps O, Riondel J, Ducros V, Rousell A-M (2005) Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mech Age Dev 126:1185-1191 (Pubitemid 41356519)
48. Berrigan D, Perkins SN, Haines DC, Hursting SD (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23:817-822 (Pubitemid 34567521)
49. Trentham-Dietz A, Newcomb PA, Egan KM et al (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533-542 (Pubitemid 30342842)
50. Mellemkjaer L, Emborg C, Gridley G et al (2001) Anorexia nervosa and cancer risk. Cancer Causes Control 12:173-177 (Pubitemid 32165275)
51. Michels KB, Ekbom A (2004) Caloric restriction and incidence of breast cancer. JAMA 291:1226-1230 (Pubitemid 38541666)
52. Harvie MN, Pegington M, Mattson MP et al (2011) The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes 35:714-727
53. Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353 (Pubitemid 38529873)
54. Peyrat JP, Bonneterre J, Hecquet B et al (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492-497 (Pubitemid 23036292)
55. Yu H, Jin F, Shu X-O et al (2002) Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11:705-712 (Pubitemid 34851903)
56. de Ostrovich KK, Lambertz I, Colgy JKL et al (2008) Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol 173:824-834
57. Hadsell DL, Bonnette SG (2000) IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia 5:19-30
58. Dunn SE, Kari FW, French JE et al (1997) Dietary restriction reduces insulin-like growth-like factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667-4672 (Pubitemid 27468963)
59. Powolny AA, Wang S, Carlton PS et al (2008) Interrelationships between dietary restriction, the IGF-I axiz, and expression of vascular endothelial growth factor by prostate adenocarcinomas in rats. Mol Carcinog 47:458-465 (Pubitemid 351822304)
60. Cleary MP, Ray A, Rogozina OP et al (2009) Targeting the adiponectin-leptin ratio for prevention of postmenopausal breast cancer. Front Biosci 1:329-357
61. Petridou E, Mantzoros C, Dessypris N et al (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88:993-997 (Pubitemid 36337745)
62. Tworoger SS, Eliassen AH, Kelesidis T et al (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510-1516 (Pubitemid 46556432)
63. Nkhata KJ, Ray A, Schuster TF et al (2009) Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep 21:1611-1619